STATEMENT BY THE BOARD OF DIRECTORS OF ALLENEX AB (PUBL) IN RELATION TO REVISED TERMS IN THE PUBLIC TAKEOVER OFFER FROM CAREDX, INC

Background

CareDx, Inc (the “Bidder”) announced on 16 December 2015 a public takeover offer
to the shareholders of Allenex AB (publ) (“Allenex”) to acquire all of the
outstanding shares of Allenex (the “Offer”). With the exception of Midroc Invest
AB, Fastpartner AB and Xenella Holding AB, the shareholders of Allenex were
offered a cash consideration of 2.50 SEK per share (the “Cash Alternative”). As
an alternative offer, a cash consideration of SEK 1.731 per share and 0.01298
shares in the Bidder per share in Allenex was offered (the “Mixed Alternative”),
which at the time of the publication of the offer corresponded to a value of
2.42
SEK[1] (http://file///C:/Users/Lars/Dropbox/IRF%202016/Allenex%202016/Statement%
2 
0by%20The%20board%20of%20directors%20regarding%20revised%20offer%20project%20Vik
i 
ng%20IRF.docx#_ftn1) per share in Allenex.

The Board of Directors announced on the same date that it had resolved to
recommend the shareholders of Allenex to accept the Offer. The Board of
Directors also emphasized that the question whether the Cash Alternative or the
Mixed Alternative is the most preferable alternative for the shareholders must
be based on an assessment of the individual shareholder of Allenex.

By way of a press release dated 9 February 2016 the Bidder has revised the terms
for the Offer as regards the Mixed Alternative. The total cash payment of 1.731
SEK per share in Allenex remains unchanged. The share component, however, is
enhanced from 0.01298 shares in the Bidder per Allenex share to 0.01458 shares
in the Bidder per Allenex share. At the time of the announcement of the revised
terms, the Mixed Alternative corresponded to a value of 2.28 SEK per share in
Allenex.[2] (http://file///C:/Users/Lars/Dropbox/IRF%202016/Allenex%202016/State
m 
ent%20by%20The%20board%20of%20directors%20regarding%20revised%20offer%20project%
2 
0Viking%20IRF.docx#_ftn2) Computed as per 15 December 2015, i.e. the last
trading day before the announcement of the Offer, the revised terms corresponds
to a value of 2.51 SEK per share in
Allenex.[3] (http://file///C:/Users/Lars/Dropbox/IRF%202016/Allenex%202016/State
m 
ent%20by%20The%20board%20of%20directors%20regarding%20revised%20offer%20project%
2 
0Viking%20IRF.docx#_ftn3) The terms for the Cash Alternative were not changed.

For further information regarding the Offer, please refer to the Bidder’s press
release dated 9 February 2016 and the offer document which the Bidder will
publish and distribute to the shareholders of Allenex.

This statement is made by the Board of Directors of Allenex pursuant to section
II.19 of the rules concerning takeover bids on the stock market adopted by
Nasdaq Stockholm (the “Takeover Rules”). The members of the Board of Directors
of Allenex Oscar Ahlgren, member of the Board of Directors of Midroc Invest AB
and Xenella Holding AB, and Sven-Olof Johansson, CEO and main shareholder of
Fastpartner AB and member of the Board of Directors of Xenella Holding AB, have,
due to conflict of interest, not participated in the preparations and
resolutions regarding issues related to the Offer. All other members of the
Board of Directors of Allenex, all of which are independent of the company, the
management and the major shareholders of the company, have participated in the
handling of the issue and the Board of Directors has therefore been quorate.

The Board of Directors’ recommendation

The Board of Directors’ earlier recommendation to the shareholders of Allenex to
accept the Offer remains.

The Board of Directors notes that there are no proposed changes to the Cash
Alternative. Whether the Cash Alternative or the Mixed Alternative is the most
preferable for a shareholder must still be based on an assessment made by the
individual shareholder of Allenex. The Board of Directors would in that context
like to draw the shareholders’ of Allenex particular attention to the fact that
the value of the consideration of the Mixed Alternative will vary over time
depending on the price of the shares of the Bidder and the USD/SEK exchange
rate.

The Board of Directors refers to its statement dated 16 December 2015 for
additional information.

This statement shall in all aspects be governed by and interpreted in accordance
with Swedish law. Any disputes relating to or arising in connection with this
statement shall be settled exclusively by Swedish courts.

Stockholm on 18 February 2016

Allenex AB (publ)

The Board of Directors

Adviser

Advokatfirman Lindahl KB is the legal adviser to Allenex.

For additional information, please contact:

Anders Williamsson, chairman of the Board of Directors of Allenex, 0708 – 72 18
65

About Allenex

Allenex is a life science company that develops, manufactures, markets and sells
products for safer transplants of organs and bone marrow on the global market.
Allenex is listed on NASDAQ Stockholm Small Cap (ticker: ALNX). 57 persons are
employed in the Allenex group.

The information in this press release shall be disclosed by Allenex AB (publ)
pursuant to the Securities Markets Act and the Takeover Rules. The information
was submitted for publication on 18 February 2016, 08.30 am (CET).

[1] (http://file///C:/Users/Lars/Dropbox/IRF%202016/Allenex%202016/Statement%20b
y 
%20The%20board%20of%20directors%20regarding%20revised%20offer%20project%20Viking
% 
20IRF.docx#_ftnref1) Based on the SEK/USD exchange rate of 8,4990 per 15
December 2015 and the closing price of the Bidder’s share in USD of 6,25 per 15
December 2015.

[2] (http://file///C:/Users/Lars/Dropbox/IRF%202016/Allenex%202016/Statement%20b
y 
%20The%20board%20of%20directors%20regarding%20revised%20offer%20project%20Viking
% 
20IRF.docx#_ftnref2) Based on the SEK/USD exchange rate of 8,4547 per 8 February
2016 and the closing price of the Bidder’s share in USD of 4,43 per 8 February
2016.

[3] (http://file///C:/Users/Lars/Dropbox/IRF%202016/Allenex%202016/Statement%20b
y 
%20The%20board%20of%20directors%20regarding%20revised%20offer%20project%20Viking
% 
20IRF.docx#_ftnref3) Based on the SEK/USD exchange rate of 8,4990 per 15
December 2015 and the closing price of the Bidder’s share in USD of 6,25 per 15
December 2015.